Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics N.V (PRQR) Change in Taxes: 2021-2024

Historic Change in Taxes for ProQR Therapeutics N.V (PRQR) over the last 2 years, with Jun 2024 value amounting to -$215,378.

  • ProQR Therapeutics N.V's Change in Taxes was N/A to -$215,378 in Q2 2024 from the same period last year, while for Jun 2024 it was -$297,092, marking a year-over-year change of. This contributed to the annual value of -$210,513 for FY2024, which is 149.50% down from last year.
  • ProQR Therapeutics N.V's Change in Taxes amounted to -$215,378 in Q2 2024, which was down 6,708.53% from $3,259 recorded in Q1 2024.
  • Over the past 5 years, ProQR Therapeutics N.V's Change in Taxes peaked at $195,887 during Q4 2022, and registered a low of -$215,378 during Q2 2024.
  • Moreover, its 3-year median value for Change in Taxes was $4,319 (2024), whereas its average is -$17,697.
  • Examining YoY changes over the last 5 years, ProQR Therapeutics N.V's Change in Taxes showed a top increase of 678.34% in 2022 and a maximum decrease of 268.55% in 2022.
  • Over the past 4 years, ProQR Therapeutics N.V's Change in Taxes (Quarterly) stood at $25,167 in 2021, then surged by 678.34% to $195,887 in 2022, then crashed by 97.25% to $5,380 in 2023, then reached -$215,378 in 2024.
  • Its Change in Taxes stands at -$215,378 for Q2 2024, versus $3,259 for Q1 2024 and $5,380 for Q4 2023.